These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 12111869)
1. Role of Bcl-2 family of proteins in malignancy. Baliga BC; Kumar S Hematol Oncol; 2002 Jun; 20(2):63-74. PubMed ID: 12111869 [TBL] [Abstract][Full Text] [Related]
2. On the link between Bcl-2 family proteins and glucocorticoid-induced apoptosis. Almawi WY; Melemedjian OK; Jaoude MM J Leukoc Biol; 2004 Jul; 76(1):7-14. PubMed ID: 15075361 [TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein l6, a novel proapoptotic Bcl-2 homology 3-only protein, induces mitochondria-mediated apoptosis in cancer cells. Liu Z; Lu H; Jiang Z; Pastuszyn A; Hu CA Mol Cancer Res; 2005 Jan; 3(1):21-31. PubMed ID: 15671246 [TBL] [Abstract][Full Text] [Related]
4. The Bcl-2 family: roles in cell survival and oncogenesis. Cory S; Huang DC; Adams JM Oncogene; 2003 Nov; 22(53):8590-607. PubMed ID: 14634621 [TBL] [Abstract][Full Text] [Related]
5. Human colon cancer cells lacking Bax resist curcumin-induced apoptosis and Bax requirement is dispensable with ectopic expression of Smac or downregulation of Bcl-XL. Rashmi R; Kumar S; Karunagaran D Carcinogenesis; 2005 Apr; 26(4):713-23. PubMed ID: 15661804 [TBL] [Abstract][Full Text] [Related]
7. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation. Hamaï A; Richon C; Meslin F; Faure F; Kauffmann A; Lecluse Y; Jalil A; Larue L; Avril MF; Chouaib S; Mehrpour M Oncogene; 2006 Dec; 25(58):7618-34. PubMed ID: 16983347 [TBL] [Abstract][Full Text] [Related]
8. Anticancer drug development based on modulation of the Bcl-2 family core apoptosis mechanism. Gardner CR Expert Rev Anticancer Ther; 2004 Dec; 4(6):1157-77. PubMed ID: 15606340 [TBL] [Abstract][Full Text] [Related]
9. Combined evaluation of expression of telomerase, survivin, and anti-apoptotic Bcl-2 family members in relation to loss of differentiation and apoptosis in human head and neck cancers. Sharma H; Sen S; Mathur M; Bahadur S; Singh N Head Neck; 2004 Aug; 26(8):733-40. PubMed ID: 15287041 [TBL] [Abstract][Full Text] [Related]
10. Bfk: a novel weakly proapoptotic member of the Bcl-2 protein family with a BH3 and a BH2 region. Coultas L; Pellegrini M; Visvader JE; Lindeman GJ; Chen L; Adams JM; Huang DC; Strasser A Cell Death Differ; 2003 Feb; 10(2):185-92. PubMed ID: 12700646 [TBL] [Abstract][Full Text] [Related]
11. A novel subclass of thalidomide analogue with anti-solid tumor activity in which caspase-dependent apoptosis is associated with altered expression of bcl-2 family proteins. Marriott JB; Clarke IA; Czajka A; Dredge K; Childs K; Man HW; Schafer P; Govinda S; Muller GW; Stirling DI; Dalgleish AG Cancer Res; 2003 Feb; 63(3):593-9. PubMed ID: 12566301 [TBL] [Abstract][Full Text] [Related]
12. BCL-2 family proteins: critical checkpoints of apoptotic cell death. Danial NN Clin Cancer Res; 2007 Dec; 13(24):7254-63. PubMed ID: 18094405 [TBL] [Abstract][Full Text] [Related]
13. Involvement of G proteins of the Rho family in the regulation of Bcl-2-like protein expression and caspase 3 activation by Gastrins. He H; Yim M; Liu KH; Cody SC; Shulkes A; Baldwin GS Cell Signal; 2008 Jan; 20(1):83-93. PubMed ID: 17936584 [TBL] [Abstract][Full Text] [Related]
14. Bcl-2 family proteins and leukemia. Minireview. Kusenda J Neoplasma; 1998; 45(3):117-22. PubMed ID: 9717521 [TBL] [Abstract][Full Text] [Related]
15. Platelet-activating factor-induced apoptosis is blocked by Bcl-2 in rat intestinal epithelial cells. Lu J; Caplan MS; Saraf AP; Li D; Adler L; Liu X; Jilling T Am J Physiol Gastrointest Liver Physiol; 2004 Feb; 286(2):G340-50. PubMed ID: 14512286 [TBL] [Abstract][Full Text] [Related]
16. Comparative genomics: the evolutionary history of the Bcl-2 family. Lanave C; Santamaria M; Saccone C Gene; 2004 May; 333():71-9. PubMed ID: 15177682 [TBL] [Abstract][Full Text] [Related]
17. Enhanced killing of melanoma cells by simultaneously targeting Mcl-1 and NOXA. Qin JZ; Xin H; Sitailo LA; Denning MF; Nickoloff BJ Cancer Res; 2006 Oct; 66(19):9636-45. PubMed ID: 17018621 [TBL] [Abstract][Full Text] [Related]
18. Targeting apoptosis as an approach for gastrointestinal cancer therapy. Qiao L; Wong BC Drug Resist Updat; 2009 Jun; 12(3):55-64. PubMed ID: 19278896 [TBL] [Abstract][Full Text] [Related]
19. Putative tumor suppressor Lats2 induces apoptosis through downregulation of Bcl-2 and Bcl-x(L). Ke H; Pei J; Ni Z; Xia H; Qi H; Woods T; Kelekar A; Tao W Exp Cell Res; 2004 Aug; 298(2):329-38. PubMed ID: 15265683 [TBL] [Abstract][Full Text] [Related]
20. Dexamethasone-induced apoptosis in acute lymphoblastic leukemia involves differential regulation of Bcl-2 family members. Laane E; Panaretakis T; Pokrovskaja K; Buentke E; Corcoran M; Söderhäll S; Heyman M; Mazur J; Zhivotovsky B; Porwit A; Grandér D Haematologica; 2007 Nov; 92(11):1460-9. PubMed ID: 18024393 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]